美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

YD Bio Ltd

18.21

+4.5633.41%

成交量：51.25萬

成交額：980.75萬

市值：12.81億

市盈率：-14.73

高：23.94

開：14.00

低：14.00

收：13.65

52周最高：31.00

52周最低：5.30

股本：7,031.98萬

流通股本：1,326.54萬

量比：2.70

換手率：3.86%

股息：- -

股息率：- -

每股收益(TTM):-1.2365

每股收益(LYR):-0.5757

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):-31.63

資料載入中...

總覽公司新聞公告

公司資料

公司名字：

YD Bio Ltd

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

12th Floor, No. 101,Section 2,Nanjing East Road,Zhongshan District,Taipei,Taiwan

官網：

- -

郵編：

54186159

電話：

- -

傳真：

- -

簡介：

YD Bio Limited於2024年2月6日在開曼群島註冊成立。他們是一家生物製藥公司，專註於基於血液的癌症檢測，開發基於干細胞和外泌體的療法，具有轉變治療具有高度未滿足醫療需求的廣譜疾病的潛力，並作為製藥公司值得信賴的臨床檢驗藥物供應商。他們的商業模式集中於與生物製藥公司發展合作夥伴關係，將創新技術轉化為商業上可行的藥物和癌症檢測。

董事

名稱

職位

J. Douglas Ramsey

Chairman of the Board, Chief Executive Officer and Chief Financial Officer

Albert McLelland

Independent Director

Bill Stark

Independent Director

James L. Williams

Independent Director

Robert Lee Thomas

Independent Director

Russell D. Griffin

President and Director

股東

名稱

職位

J. Douglas Ramsey

Chairman of the Board, Chief Executive Officer and Chief Financial Officer

Charles C. Ross

Chief Operating Officer

Russell D. Griffin

President and Director

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/YDES/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"YDES","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"YDES\",,,,,undefined,":{"symbol":"YDES","market":"US","secType":"STK","nameCN":"YD Bio Ltd","latestPrice":18.21,"timestamp":1756924617873,"preClose":13.65,"halted":0,"volume":512544,"delay":0,"floatShares":13265400,"shares":70319824,"eps":-1.236523,"marketStatus":"交易中","change":4.56,"latestTime":"09-03 14:37:06 EDT","open":14,"high":23.9426,"low":14,"amount":9807544.303776,"amplitude":0.728396,"askPrice":18.6,"askSize":100,"bidPrice":18.11,"bidSize":104,"shortable":3,"etf":0,"ttmEps":-1.236523,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1756929600000},"marketStatusCode":2,"adr":0,"listingDate":1756440000000,"exchange":"NASDAQ","adjPreClose":13.65,"preHourTrading":{"tag":"盘前","latestPrice":14.1,"preClose":13.65,"latestTime":"09:29 EDT","volume":8832,"amount":124879.30444800001,"timestamp":1756906191041},"postHourTrading":{"tag":"盘后","latestPrice":13.97,"preClose":13.65,"latestTime":"19:43 EDT","volume":2782,"amount":36935.52,"timestamp":1756856610219},"volumeRatio":2.701058},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"YDES\",,,,,undefined,":{"symbol":"YDES","floatShares":13265400,"roa":"--","roe":"--","lyrEps":-0.575707,"volumeRatio":2.701058,"shares":70319824,"dividePrice":0,"high":23.9426,"amplitude":0.728396,"preClose":13.65,"low":14,"week52Low":5.3,"pbRate":"--","week52High":31,"institutionHeld":0,"latestPrice":18.21,"committee":0.019608,"eps":-1.236523,"divideRate":0,"volume":512544,"delay":0,"ttmEps":-1.236523,"open":14,"prevYearClose":11.25,"prevWeekClose":12.5,"prevMonthClose":12.5,"prevQuarterClose":12.69,"fiveDayClose":13.36,"twentyDayClose":12.04,"sixtyDayClose":11.87},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/YDES\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-19","symbol":"YDES","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1755576000000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"YDES\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"YDES\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1898493574,"address":"12th Floor, No. 101,Section 2,Nanjing East Road,Zhongshan District,Taipei,Taiwan","zipCode":"54186159"},"stockCompanyDetail":{"stockEarnings":[{"period":"1week","weight":0.0217},{"period":"1month","weight":0.1347},{"period":"3month","weight":0.1519},{"period":"6month","weight":0.2616},{"period":"1year","weight":0.2123},{"period":"ytd","weight":0.2133}],"compareEarnings":[{"period":"1week","weight":-0.0076},{"period":"1month","weight":0.0298},{"period":"3month","weight":0.0744},{"period":"6month","weight":0.118},{"period":"1year","weight":0.1359},{"period":"ytd","weight":0.0925}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"YD Bio Limited於2024年2月6日在開曼群島註冊成立。他們是一家生物製藥公司，專註於基於血液的癌症檢測，開發基於干細胞和外泌體的療法，具有轉變治療具有高度未滿足醫療需求的廣譜疾病的潛力，並作為製藥公司值得信賴的臨床檢驗藥物供應商。他們的商業模式集中於與生物製藥公司發展合作夥伴關係，將創新技術轉化為商業上可行的藥物和癌症檢測。","exchange":"NASDAQ","name":"YD Bio Ltd","nameEN":"YD Bio Ltd"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"YDES\",market:\"US\",,,undefined,":{"directors":[{"name":"J. Douglas Ramsey","position":"Chairman of the Board, Chief Executive Officer and Chief Financial Officer"},{"name":"Albert McLelland","position":"Independent Director"},{"name":"Bill Stark","position":"Independent Director"},{"name":"James L. Williams","position":"Independent Director"},{"name":"Robert Lee Thomas","position":"Independent Director"},{"name":"Russell D. Griffin","position":"President and Director"}],"executives":[{"name":"J. Douglas Ramsey","position":"Chairman of the Board, Chief Executive Officer and Chief Financial Officer"},{"name":"Charles C. Ross","position":"Chief Operating Officer"},{"name":"Russell D. Griffin","position":"President and Director"}]}}}